Screening for SNCA and LRRK2 mutations in Greek sporadic and autosomal dominant Parkinson's disease: Identification of two novel LRRK2 variants

European Journal of Neurology

Volumn 14, Issue 1, 2007, Pages 7-11

  Xiromerisiou, G ^a,b   Hadjigeorgiou, G M ^a   Gourbali, V ^a   Johnson, J ^b   Papakonstantinou, I ^c   Papadimitriou, A ^a   Singleton, A B ^b  

^a UNIVERSITY OF THESSALY   (Greece)

^b NATIONAL INSTITUTE ON AGING   (United States)

^c General Hospital of Trikala   (Greece)

Author keywords

Alpha synuclein gene; Leucine rich repeat kinase 2 gene; Mutation; Parkinson's disease

Indexed keywords

ALPHA SYNUCLEIN; GENOMIC DNA; LEUCINE RICH REPEAT KINASE 2;

ADULT; AGED; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CONTROLLED STUDY; FEMALE; GENE DOSAGE; GENE IDENTIFICATION; GENE MUTATION; GENE SEQUENCE; GENETIC SCREENING; GENETIC VARIABILITY; GREECE; HUMAN; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; MUTATION RATE; MUTATIONAL ANALYSIS; PARKINSON DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; ALPHA-SYNUCLEIN; FEMALE; GENETIC SCREENING; GREECE; HUMANS; MALE; MIDDLE AGED; MUTATION; PARKINSON DISEASE; PARKINSONIAN DISORDERS; PROTEIN-SERINE-THREONINE KINASES; VARIATION (GENETICS);

EID: 33846137663     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2006.01551.x     Document Type: Article

References (22)

1. de Rijk MC, Launer LJ, Berger K, et al. Prevalence of Parkinson's disease in Europe: a collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology 2000; 54(Suppl. 5): S21-S23.
2. Payami H, Larsen K, Bernard S, Nutt J. Increased risk of Parkinson's disease in parents and siblings of patients. Annals of Neurology 1994; 36: 659-661.
3. Polymeropoulos MH, Lavedan C, Leroy E, et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 1997; 276: 2045-2047.
4. Kruger R, Kuhn W, Muller T, et al. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nature Genetics 1998; 18: 106-108.
5. Zarranz JJ, Alegre J, Gomez-Esteban JC, et al. The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Annals of Neurology 2004; 55: 164-173.
6. Singleton AB, Farrer M, Johnson J, et al. Alpha-synuclein locus triplication causes Parkinson's disease. Science 2003; 302: 841.
7. Ibanez P, Bonnet AM, Debarges B, et al. Causal relation between alpha-synuclein gene duplication and familial Parkinson's disease. Lancet 2004; 364: 1169-1171.
8. Farrer M, Kachergus J, Forno L, et al. Comparison of kindreds with parkinsonism and alpha-synuclein genomic multiplications. Annals of Neurology 2004; 55: 174-179.
9. Paisan-Ruiz C, Jain S, Evans EW, et al. Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron 2004; 44: 595-600.
10. Zimprich A, Biskup S, Leitner P, et al. Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 2004; 44: 601-607.
11. Di Fonzo A, Rohe CF, Ferreira J, et al. A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease. Lancet 2005; 365: 412-415.
12. Gilks WP, Abou-Sleiman PM, Gandhi S, et al. A common LRRK2 mutation in idiopathic Parkinson's disease. Lancet 2005; 365: 415-416.
13. Nichols WC, Pankratz N, Hernandez D, et al. Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease. Lancet 2005; 365: 410-412.
14. Kachergus J, Mata IF, Hulihan M, et al. Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populations. American Journal of Human Genetics 2005; 76: 672-680.
15. Papadimitriou A, Veletza V, Hadjigeorgiou GM, Patrikiou A, Hirano M, Anastasopoulos I. Mutated alpha-synuclein gene in two Greek kindreds with familial PD: incomplete penetrance? Neurology 1999; 52: 651-654.
16. Bostantjopoulou S, Katsarou Z, Papadimitriou A, Veletza V, Hatzigeorgiou G, Lees A. Clinical features of parkinsonian patients with the alpha-synuclein (G209A) mutation. Movement Disorders 2001; 16: 1007-1013.
17. Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson disease. Archives of Neurology 1999; 56: 33-39.
18. Lesage S, Ibanez P, Lohmann E, et al. G2019S LRRK2 mutation in French and North African families with Parkinson's disease. Annals of Neurology 2005; 58: 784-787.
19. Tan EK, Shen H, Tan LC, et al. The G2019S LRRK2 mutation is uncommon in an Asian cohort of Parkinson's disease patients. Neuroscience Letters 2005; 384: 327-329.
20. Paisan-Ruiz C, Lang AE, Kawarai T, et al. LRRK2 gene in Parkinson disease: mutation analysis and case control association study. Neurology 2005; 65: 696-700.
21. Singleton AB. Altered alpha-synuclein homeostasis causing Parkinson's disease: the potential roles of dardarin. Trends in Neurosciences 2005; 28: 416-421.
22. Hernandez DG, Paisan-Ruiz C, McInerney-Leo A, et al. Clinical and positron emission tomography of Parkinson's disease caused by LRRK2. Annals of Neurology 2005; 57: 453-456.